BRIEF-Ptc Therapeutics Provides Update At J.P. Morgan Annual Healthcare Conference

PTC Therapeutics, Inc. -1.43%

PTC Therapeutics, Inc.

PTCT

67.77

-1.43%

Jan 12 (Reuters) - PTC Therapeutics Inc PTCT.O:

  • PTC THERAPEUTICS PROVIDES UPDATE AT J.P. MORGAN ANNUAL HEALTHCARE CONFERENCE

  • PTC THERAPEUTICS INC - 2026 PRODUCT REVENUE GUIDANCE OF $700 – 800M

  • PTC THERAPEUTICS INC - UNAUDITED 2025 TOTAL PRODUCT AND ROYALTY REVENUE OF APPROXIMATELY $823M, EXCEEDING GUIDANCE

  • PTC THERAPEUTICS INC - SEPHIENCE LAUNCH CONTINUES WITH UNAUDITED Q4 GLOBAL REVENUE OF $92.5M

Source text: ID:nPn6xgw3sa

Further company coverage: PTCT.O


((Reuters.Briefs@thomsonreuters.com;))

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.